Wall Street Zen Downgrades Sanofi (NASDAQ:SNY) to Hold

Sanofi (NASDAQ:SNY) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

A number of other research analysts have also commented on SNY. Argus raised Sanofi to a “strong-buy” rating in a research report on Monday, April 27th. Weiss Ratings upgraded Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. BNP Paribas Exane cut Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 target price on the stock. in a research note on Monday, April 20th. Morgan Stanley set a $49.00 target price on Sanofi in a report on Wednesday, July 8th. Finally, Citigroup restated a “neutral” rating on shares of Sanofi in a report on Monday, April 13th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, Sanofi currently has an average rating of “Hold” and an average price target of $49.50.

Sanofi Price Performance

Shares of Sanofi stock opened at $44.66 on Friday. The company’s fifty day simple moving average is $43.35 and its two-hundred day simple moving average is $45.50. Sanofi has a 12-month low of $40.89 and a 12-month high of $52.68. The firm has a market cap of $108.28 billion, a PE ratio of 12.47, a price-to-earnings-growth ratio of 1.14 and a beta of 0.34. The company has a quick ratio of 0.22, a current ratio of 1.01 and a debt-to-equity ratio of 0.17.

Institutional Trading of Sanofi

Institutional investors and hedge funds have recently bought and sold shares of the stock. Advisory Services Network LLC lifted its holdings in Sanofi by 1.4% in the third quarter. Advisory Services Network LLC now owns 15,733 shares of the company’s stock valued at $743,000 after acquiring an additional 210 shares during the period. Savant Capital LLC increased its holdings in shares of Sanofi by 2.7% during the 4th quarter. Savant Capital LLC now owns 8,623 shares of the company’s stock valued at $418,000 after purchasing an additional 225 shares in the last quarter. Wesbanco Bank Inc. lifted its stake in shares of Sanofi by 4.9% in the 4th quarter. Wesbanco Bank Inc. now owns 4,927 shares of the company’s stock valued at $239,000 after purchasing an additional 230 shares during the period. IFG Advisory LLC lifted its stake in shares of Sanofi by 2.7% in the 4th quarter. IFG Advisory LLC now owns 9,213 shares of the company’s stock valued at $446,000 after purchasing an additional 244 shares during the period. Finally, Cohen Investment Advisors LLC boosted its holdings in Sanofi by 2.9% during the first quarter. Cohen Investment Advisors LLC now owns 9,480 shares of the company’s stock worth $457,000 after buying an additional 263 shares in the last quarter. 14.03% of the stock is currently owned by hedge funds and other institutional investors.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.